Skip to content

Commit

Permalink
Merge pull request #77 from malariagen/gaard-terms-of-use
Browse files Browse the repository at this point in the history
Update terms of use
  • Loading branch information
ahernank authored Aug 5, 2024
2 parents 9151427 + c575893 commit 36ac45d
Show file tree
Hide file tree
Showing 2 changed files with 8 additions and 1 deletion.
2 changes: 1 addition & 1 deletion docs/af1/af1.0.ipynb
Original file line number Diff line number Diff line change
Expand Up @@ -30,7 +30,7 @@
"\n",
"The publication embargo for all data on this release will expire on the **29th of April 2026**. \n",
"\n",
"If you have any questions about the terms of use, please email support@malariagen.net. If you are planning to analyse `Af1.0` data before the expiry of the publication embargo and/or would like to use it outside of the terms of use specified above, please also contact [Dr Mara Lawniczak](mara@sanger.ac.uk)."
"If you have any questions about the terms of use, please email support@malariagen.net. If you are planning to analyse `Af1.0` data before the expiry of the publication embargo and/or would like to use it outside of the terms of use specified above, please also contact Dr Mara Lawniczak (mara@sanger.ac.uk)."
]
},
{
Expand Down
7 changes: 7 additions & 0 deletions docs/ag3/ag3.2.ipynb
Original file line number Diff line number Diff line change
Expand Up @@ -31,6 +31,13 @@
"\n",
"The publication embargo for all data on this release will expire on the **17th of November 2025**. \n",
"\n",
"Please note, within this release, the study partner has waived the embargo for the following sample sets: \n",
"* `1237-VO-BJ-DJOGBENOU-VMF00050` - 90 samples\n",
"* `1237-VO-BJ-DJOGBENOU-VMF00067` - 142 samples\n",
"* `1244-VO-GH-YAWSON-VMF00051` - 666 samples\n",
"* `1245-VO-CI-CONSTANT-VMF00054` - 38 samples\n",
"* `1253-VO-TG-DJOGBENOU-VMF00052` - 179 samples\n",
"\n",
"If you have any questions about the terms of use, please email support@malariagen.net"
]
},
Expand Down

0 comments on commit 36ac45d

Please sign in to comment.